Outcomes of Severe ARDS COVID-19 Patients Denied for Venovenous ECMO Support: A Prospective Observational Comparative Study

Overview

Journal J Clin Med

Specialty General Medicine

Date 2024 Apr 9

PMID 38592410

Authors

Aude Sylvestre

Jean-Marie Forel

Laura Textoris

Ines Gragueb-Chatti

Florence Daviet

Saida Salmi

Melanie Adda

Antoine Roch

Laurent Papazian

Sami Hraiech

Christophe Guervilly

Affiliations

Soon will be listed here.

Abstract

: Few data are available concerning the outcome of patients denied venovenous extracorporeal membrane oxygenation (VV-ECMO) relative to severe acute respiratory distress syndrome (ARDS) due to COVID-19. : We compared the 90-day survival rate of consecutive adult patients for whom our center was contacted to discuss VV-ECMO indication. Three groups of patients were created: patients for whom VV-ECMO was immediately indicated (ECMO-indicated group), patients for whom VV-ECMO was not indicated at the time of the call (ECMO-not-indicated group), and patients for whom ECMO was definitely contraindicated (ECMO-contraindicated group). : In total, 104 patients were referred for VV-ECMO support due to severe COVID-19 ARDS. Among them, 32 patients had immediate VV-ECMO implantation, 28 patients had no VV-ECMO indication, but 1 was assisted thereafter, and 44 patients were denied VV-ECMO for contraindication. Among the 44 patients denied, 30 were denied for advanced age, 24 for excessive prior duration of mechanical ventilation, and 16 for SOFA score >8. The 90-day survival rate was similar for the ECMO-indicated group and the ECMO-not-indicated group at 62.1 and 61.9%, respectively, whereas it was significantly lower (20.5%) for the ECMO-contraindicated group. : Despite a low survival rate, 50% of patients were at home 3 months after being denied for VV-ECMO for severe ARDS due to COVID-19.

References

Schmidt M, Zogheib E, Roze H, Repesse X, Lebreton G, Luyt C . The PRESERVE mortality risk score and analysis of long-term outcomes after extracorporeal membrane oxygenation for severe acute respiratory distress syndrome. Intensive Care Med. 2013; 39(10):1704-13. PMC: 7094902. DOI: 10.1007/s00134-013-3037-2. View

Schmidt M, Hajage D, Lebreton G, Dres M, Guervilly C, Richard J . Prone Positioning During Extracorporeal Membrane Oxygenation in Patients With Severe ARDS: The PRONECMO Randomized Clinical Trial. JAMA. 2023; 330(24):2343-2353. PMC: 10692949. DOI: 10.1001/jama.2023.24491. View

Karagiannidis C, Strassmann S, Merten M, Bein T, Windisch W, Meybohm P . High In-Hospital Mortality Rate in Patients with COVID-19 Receiving Extracorporeal Membrane Oxygenation in Germany: A Critical Analysis. Am J Respir Crit Care Med. 2021; 204(8):991-994. PMC: 8534613. DOI: 10.1164/rccm.202105-1145LE. View

Bartlett R, Ogino M, Brodie D, McMullan D, Lorusso R, MacLaren G . Initial ELSO Guidance Document: ECMO for COVID-19 Patients with Severe Cardiopulmonary Failure. ASAIO J. 2020; 66(5):472-474. PMC: 7273858. DOI: 10.1097/MAT.0000000000001173. View

Levy D, Lebreton G, De Chambrun M, Hekimian G, Chommeloux J, Brechot N . Outcomes of Patients Denied Extracorporeal Membrane Oxygenation during the COVID-19 Pandemic in Greater Paris, France. Am J Respir Crit Care Med. 2021; 204(8):994-997. PMC: 8534624. DOI: 10.1164/rccm.202105-1312LE. View

Hermann M, Laxar D, Krall C, Hafner C, Herzog O, Kimberger O . Duration of invasive mechanical ventilation prior to extracorporeal membrane oxygenation is not associated with survival in acute respiratory distress syndrome caused by coronavirus disease 2019. Ann Intensive Care. 2022; 12(1):6. PMC: 8755897. DOI: 10.1186/s13613-022-00980-3. View

Deatrick K, Mazzeffi M, Galvagno Jr S, Tesoriero R, Kaczoroswki D, Herr D . Outcomes of Venovenous Extracorporeal Membrane Oxygenation When Stratified by Age: How Old Is Too Old?. ASAIO J. 2020; 66(8):946-951. DOI: 10.1097/MAT.0000000000001076. View

Parzy G, Daviet F, Puech B, Sylvestre A, Guervilly C, Porto A . Venous Thromboembolism Events Following Venovenous Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Syndrome Coronavirus 2 Based on CT Scans. Crit Care Med. 2020; 48(10):e971-e975. PMC: 7328443. DOI: 10.1097/CCM.0000000000004504. View

Snyder M, Njie B, Grabenstein I, Viola S, Abbas H, Bhatti W . Functional recovery in a cohort of ECMO and non-ECMO acute respiratory distress syndrome survivors. Crit Care. 2023; 27(1):440. PMC: 10644522. DOI: 10.1186/s13054-023-04724-y. View

10.

Guervilly C, Bousquet G, Arnaud L, Gragueb-Chatti I, Daviet F, Adda M . Microvesicles Are Associated with Early Veno Venous ECMO Circuit Change during Severe ARDS: A Prospective Observational Pilot Study. J Clin Med. 2023; 12(23). PMC: 10707592. DOI: 10.3390/jcm12237281. View

11.

Chommeloux J, Valentin S, Winiszewski H, Adda M, De Chambrun M, Moyon Q . One-Year Mental and Physical Health Assessment in Survivors after Extracorporeal Membrane Oxygenation for COVID-19-related Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med. 2022; 207(2):150-159. PMC: 9893333. DOI: 10.1164/rccm.202206-1145OC. View

12.

Combes A, Hajage D, Capellier G, Demoule A, Lavoue S, Guervilly C . Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome. N Engl J Med. 2018; 378(21):1965-1975. DOI: 10.1056/NEJMoa1800385. View

13.

Schmidt M, Hajage D, Landoll M, Pequignot B, Langouet E, Amalric M . Comparative outcomes of extracorporeal membrane oxygenation for COVID-19 delivered in experienced European centres during successive SARS-CoV-2 variant outbreaks (ECMO-SURGES): an international, multicentre, retrospective cohort study. Lancet Respir Med. 2023; 11(2):163-175. PMC: 9889098. DOI: 10.1016/S2213-2600(22)00438-6. View

14.

Schmidt M, Bailey M, Sheldrake J, Hodgson C, Aubron C, Rycus P . Predicting survival after extracorporeal membrane oxygenation for severe acute respiratory failure. The Respiratory Extracorporeal Membrane Oxygenation Survival Prediction (RESP) score. Am J Respir Crit Care Med. 2014; 189(11):1374-82. DOI: 10.1164/rccm.201311-2023OC. View

15.

Pappalardo F, Pieri M, Greco T, Patroniti N, Pesenti A, Arcadipane A . Predicting mortality risk in patients undergoing venovenous ECMO for ARDS due to influenza A (H1N1) pneumonia: the ECMOnet score. Intensive Care Med. 2012; 39(2):275-81. PMC: 7095375. DOI: 10.1007/s00134-012-2747-1. View

16.

Provaznik Z, Philipp A, Muller T, Kostiantyn K, Lunz D, Schmid C . Outcome after veno-venous extracorporeal membrane oxygenation in elderly compared to younger patients: A 14-year retrospective observational study. Artif Organs. 2022; 47(5):882-890. DOI: 10.1111/aor.14454. View

17.

Barbaro R, MacLaren G, Boonstra P, Iwashyna T, Slutsky A, Fan E . Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Organization registry. Lancet. 2020; 396(10257):1071-1078. PMC: 7518880. DOI: 10.1016/S0140-6736(20)32008-0. View

18.

Gillon S, Rowland K, Shankar-Hari M, Camporota L, Glover G, Wyncoll D . Acceptance and transfer to a regional severe respiratory failure and veno-venous extracorporeal membrane oxygenation (ECMO) service: predictors and outcomes. Anaesthesia. 2017; 73(2):177-186. DOI: 10.1111/anae.14083. View

19.

Chandel A, Puri N, Damuth E, Potestio C, Peterson L, Ledane J . Extracorporeal Membrane Oxygenation for COVID-19: Comparison of Outcomes to Non-COVID-19-Related Viral Acute Respiratory Distress Syndrome From the Extracorporeal Life Support Organization Registry. Crit Care Explor. 2023; 5(2):e0861. PMC: 9901999. DOI: 10.1097/CCE.0000000000000861. View

20.

Supady A, DellaVolpe J, Taccone F, Scharpf D, Ulmer M, Lepper P . Outcome Prediction in Patients with Severe COVID-19 Requiring Extracorporeal Membrane Oxygenation-A Retrospective International Multicenter Study. Membranes (Basel). 2021; 11(3). PMC: 7997249. DOI: 10.3390/membranes11030170. View